CA3199545A1 - Compositions and methods for the treatment of hypertension - Google Patents

Compositions and methods for the treatment of hypertension

Info

Publication number
CA3199545A1
CA3199545A1 CA3199545A CA3199545A CA3199545A1 CA 3199545 A1 CA3199545 A1 CA 3199545A1 CA 3199545 A CA3199545 A CA 3199545A CA 3199545 A CA3199545 A CA 3199545A CA 3199545 A1 CA3199545 A1 CA 3199545A1
Authority
CA
Canada
Prior art keywords
weight
oil
carriers
cbd
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3199545A
Other languages
English (en)
French (fr)
Inventor
John Docherty
Christopher Andrew Bunko
Original Assignee
Poviva Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/857,985 external-priority patent/US11666544B1/en
Priority claimed from US17/857,991 external-priority patent/US11980593B2/en
Application filed by Poviva Corp filed Critical Poviva Corp
Publication of CA3199545A1 publication Critical patent/CA3199545A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053Compositions other than spreads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA3199545A 2022-07-05 2023-04-25 Compositions and methods for the treatment of hypertension Pending CA3199545A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17/857,991 2022-07-05
US17/857,985 US11666544B1 (en) 2022-07-05 2022-07-05 Compositions and methods for treating hypertension
US17/857,985 2022-07-05
US17/857,991 US11980593B2 (en) 2022-07-05 2022-07-05 Compositions and methods for treating hypertension
PCT/US2023/019789 WO2024010629A1 (en) 2022-07-05 2023-04-25 Compositions and methods for treating hypertension

Publications (1)

Publication Number Publication Date
CA3199545A1 true CA3199545A1 (en) 2025-01-31

Family

ID=89453914

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3199545A Pending CA3199545A1 (en) 2022-07-05 2023-04-25 Compositions and methods for the treatment of hypertension

Country Status (6)

Country Link
EP (1) EP4346802A4 (de)
JP (1) JP7823052B2 (de)
AU (1) AU2023237124A1 (de)
CA (1) CA3199545A1 (de)
MX (1) MX2023011494A (de)
WO (1) WO2024010629A1 (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3283065A4 (de) * 2015-12-09 2018-12-26 Poviva Tea, LLC Verfahren zur formulierung oral einnehmbarer zusammensetzungen mit lipophilen wirkstoffen
JP6893012B2 (ja) * 2017-07-18 2021-06-23 徳義制薬有限公司Deyi Pharmarmaceutical Ltd. 肺高血圧症の治療におけるカンナビジオールの応用
US20200315965A1 (en) * 2019-04-02 2020-10-08 Cannasol Technologies, Llc Nanoemulsion concentrate formulations and methods
JP2022533837A (ja) * 2019-05-20 2022-07-26 ポビバ コーポレーション 生物活性物質と胆汁酸塩を含む組成物
JP2021031485A (ja) * 2020-02-06 2021-03-01 株式会社中島商会 Cbdオイルの製造方法
US20210299062A1 (en) * 2020-03-29 2021-09-30 Mark J. Rosenfeld Cannabinoid compositions and methods of treatment
CA3172889C (en) * 2020-04-20 2024-05-28 John Docherty Compositions and methods for enhanced delivery of antiviral agents
CN114177163B (zh) * 2022-01-12 2023-05-02 刘树民 一种治疗高血压的药物

Also Published As

Publication number Publication date
JP7823052B2 (ja) 2026-03-03
MX2023011494A (es) 2024-01-18
EP4346802A1 (de) 2024-04-10
AU2023237124A1 (en) 2024-01-25
JP2024528761A (ja) 2024-08-01
WO2024010629A1 (en) 2024-01-11
EP4346802A4 (de) 2024-12-25

Similar Documents

Publication Publication Date Title
US11666544B1 (en) Compositions and methods for treating hypertension
US11666543B1 (en) Pharmaceutical compositions and methods for treating hypertension
US6245326B1 (en) Health supplement
JP6073998B2 (ja) 粘土組成物
FR2673812A1 (fr) Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
CN103889246A (zh) 诱导产生饱腹感的方法和组合物
KR102419759B1 (ko) 고 약물 부하량의 중쇄 트리글리세라이드를 갖는 약학 조성물 및 이와 관련된 방법
CN105073129A (zh) 用于糖尿病的口服治疗的药物组合物
US12220422B1 (en) Compositions and methods for treating epilepsy
CN112426403A (zh) 一种口腔溃疡凝胶及其制备方法和应用
CA3173107A1 (en) Composition comprising antimicrobial agent and its uses
AU2023302884B2 (en) Pharmaceutical compositions and methods for treating hypertension
US11980593B2 (en) Compositions and methods for treating hypertension
CA3199545A1 (en) Compositions and methods for the treatment of hypertension
WO2024010628A1 (en) Pharmaceutical compositions and methods for treating hypertension
US20240009140A1 (en) Pharmaceutical compositions and methods for treating hypertension
JP2005528353A (ja) 糖尿病に関連する症状及び糖尿病の合併症を包含する糖尿病の治療方法
FR2882933A1 (fr) Utilisation d'un extrait d'oignon pour la fabrication d'une composition pour controler la prise de poids
JPS63215640A (ja) 易吸収性抗炎症剤及びその製造方法
US20250032516A1 (en) Compositions and methods for treating epilepsy
JPS6260369B2 (de)
CN108201541A (zh) 富勒烯结构在制备增强胰岛素敏感性的药物中的应用
AU747388B2 (en) Health supplement
EP2478902A1 (de) Pharmazeutische zusammensetzung zur gewichtsreduktion und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION PUBLISHED (OPEN TO PUBLIC INSPECTION)

Effective date: 20250131

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251010

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251110

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251110

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260225

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260225